Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib
(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end 2020) FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at…